These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3719956)

  • 21. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.
    Berria R; Gastaldelli A; Lucidi S; Belfort R; De Filippis E; Easton C; Brytzki R; Cusi K; Jovanovic L; DeFronzo R
    Clin Pharmacol Ther; 2006 Aug; 80(2):105-14. PubMed ID: 16890572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
    Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods.
    Miller KK; Rosner W; Lee H; Hier J; Sesmilo G; Schoenfeld D; Neubauer G; Klibanski A
    J Clin Endocrinol Metab; 2004 Feb; 89(2):525-33. PubMed ID: 14764757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic and cardiovascular changes in women with polycystic ovary syndrome.
    Meden-Vrtovec H; Vrtovec B; Osredkar J
    Int J Gynaecol Obstet; 2007 Nov; 99(2):87-90. PubMed ID: 17900581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Which hormone tests for the diagnosis of polycystic ovary syndrome?
    Robinson S; Rodin DA; Deacon A; Wheeler MJ; Clayton RN
    Br J Obstet Gynaecol; 1992 Mar; 99(3):232-8. PubMed ID: 1296589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum testosterone levels in the polycystic ovary syndrome. Effect of an estrogen-progestin on protein binding of testosterone.
    Easterling WE; Talbert LM; Potter HD
    Am J Obstet Gynecol; 1974 Oct; 120(3):385-9. PubMed ID: 4415747
    [No Abstract]   [Full Text] [Related]  

  • 27. [Circulating free-testosterone and SHBG levels before and after ovarian wedge resection in patients with polycystic ovarian disease].
    Oikawa M; Tanaka T; Ohkochi T; Yamamoto R; Sakuragi N; Fujimoto S; Ichinoe K
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Apr; 39(4):689-90. PubMed ID: 3585114
    [No Abstract]   [Full Text] [Related]  

  • 28. [Radio-immunological determination of testosterone and of sexual hormone binding globulin in plasma of women with hirsutism (author's transl)].
    Warenik-Szymankiewicz A; Baron J; Chwalisz K
    Zentralbl Gynakol; 1980; 102(9):502-6. PubMed ID: 7193391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The therapeutic effect of parlodel in the polycystic ovary syndrome].
    Soboleva EL; Komarov EK; Potin VV; Svechnikova FA
    Akush Ginekol (Mosk); 1990 Sep; (9):61-3. PubMed ID: 2278313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polycystic ovary disease in two patients with Briquet's disorder.
    Orenstein H; Raskind MA
    Am J Psychiatry; 1983 Sep; 140(9):1202-4. PubMed ID: 6412573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the free androgen index a useful clinical marker in male patients?
    Brannian JD; Long P; Kreger DO
    S D J Med; 1998 Dec; 51(12):449-51. PubMed ID: 9871405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reassessing Free-Testosterone Calculation by Liquid Chromatography-Tandem Mass Spectrometry Direct Equilibrium Dialysis.
    Fiers T; Wu F; Moghetti P; Vanderschueren D; Lapauw B; Kaufman JM
    J Clin Endocrinol Metab; 2018 Jun; 103(6):2167-2174. PubMed ID: 29618085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug correction of hormonal disturbances and risk factors of cardiovascular complications in women of reproductive age with polycystic ovary syndrome].
    Chernukha GE; Karpov IuA; Balakhonova TV; Blinova IV
    Kardiologiia; 2010; 50(12):59-63. PubMed ID: 21591394
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of a low-dose oral contraceptive on serum testosterone levels in polycystic ovary disease.
    Talbert LM; Sloan C
    Obstet Gynecol; 1979 Jun; 53(6):694-7. PubMed ID: 572024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome.
    Tropeano G; Lucisano A; Liberale I; Barini A; Vuolo IP; Martino G; Menini E; Dell'Acqua S
    J Clin Endocrinol Metab; 1994 Feb; 78(2):305-9. PubMed ID: 8106616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma androgens in patients with the polycystic overy syndrome.
    Horton R; Neisler J
    J Clin Endocrinol Metab; 1968 Apr; 28(4):479-84. PubMed ID: 5643867
    [No Abstract]   [Full Text] [Related]  

  • 37. [Change in the estradiol, progesterone and testosterone levels in the blood plasma in Stein-Leventhal syndrome].
    Dokumov S; Maleeva A; Volkov I
    Akush Ginekol (Mosk); 1978 Aug; (8):33-5. PubMed ID: 707750
    [No Abstract]   [Full Text] [Related]  

  • 38. Testosterone Levels in Third Trimester in Polycystic Ovary Syndrome: Odense Child Cohort.
    Glintborg D; Jensen RC; Bentsen K; Schmedes AV; Brandslund I; Kyhl HB; Bilenberg N; Andersen MS
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3819-3827. PubMed ID: 30060213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of spironolactone on testosterone and LHRH responsiveness in women with polycystic ovarian disease.
    Evron S; Yosef SM; Schenker JG; Diamant YZ
    Isr J Med Sci; 1984 Jul; 20(7):630-3. PubMed ID: 6432730
    [No Abstract]   [Full Text] [Related]  

  • 40. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease.
    Burghen GA; Givens JR; Kitabchi AE
    J Clin Endocrinol Metab; 1980 Jan; 50(1):113-6. PubMed ID: 7350174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.